J Chao Selected Research

J Chao Research Topics

Disease

9	Neoplasms (Cancer) 10/2022 - 07/2000
6	Fibrosis (Cirrhosis) 11/2001 - 08/2000
5	Hypertension (High Blood Pressure) 09/2004 - 08/2000
4	Sclerosis 11/2001 - 09/2000
4	Neointima 01/2001 - 03/2000
3	Adenocarcinoma 10/2022 - 11/2001
3	Microsatellite Instability 10/2022 - 01/2019
3	Crohn Disease (Crohn's Disease) 11/2010 - 11/2008
3	Hypertrophy 09/2004 - 08/2000
3	Wounds and Injuries (Trauma) 09/2004 - 05/2001
3	Myocardial Ischemia (Ischemic Heart Diseases) 12/2001 - 01/2000
3	Ischemia 07/2001 - 01/2001
3	Cardiomegaly (Heart Hypertrophy) 06/2001 - 09/2000
2	Inflammation (Inflammations) 12/2021 - 08/2000
2	Fatigue 02/2014 - 06/2005
2	Hyperplasia 12/2001 - 01/2000
2	Myocardial Infarction 11/2001 - 01/2000
2	Reperfusion Injury 11/2001 - 01/2000
2	Hypotension (Low Blood Pressure) 05/2001 - 03/2000
2	Vascular Remodeling 01/2001 - 06/2000
1	Silicosis 12/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Weight Gain 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Disease Progression 03/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2019
1	Eczema 01/2019
1	Atopic Dermatitis (Atopic Eczema) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Pruritus (Itching) 01/2019
1	Esophageal Neoplasms (Esophageal Cancer) 09/2018
1	Liver Neoplasms (Liver Cancer) 10/2016
1	Hip Osteoarthritis (Coxarthrosis) 01/2016
1	Pain (Aches) 01/2016
1	Fistula 11/2010
1	Hypersensitivity (Allergy) 10/2009
1	Essential Hypertension 09/2005
1	Heart Failure 12/2001
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2001
1	Renal Insufficiency (Renal Failure) 12/2001
1	Breast Neoplasms (Breast Cancer) 11/2001
1	Neoplasm Metastasis (Metastasis) 11/2001
1	Ovarian Neoplasms (Ovarian Cancer) 10/2001
1	Ovarian Epithelial Carcinoma 10/2001

Drug/Important Bio-Agent (IBA)

8	Tissue Kallikreins (Tissue Kallikrein)IBA 09/2005 - 01/2000
6	Proteins (Proteins, Gene)FDA Link 12/2021 - 08/2000
5	Kallikreins (Kallikrein)IBA 09/2004 - 01/2000
5	KininsIBA 01/2001 - 01/2000
4	Complementary DNA (cDNA)IBA 09/2004 - 03/2000
4	2,5-dichloro-4-bromophenol (B 2)IBA 01/2001 - 01/2000
3	Adalimumab (Humira)FDA Link 11/2010 - 11/2008
3	AdrenomedullinIBA 06/2001 - 09/2000
3	BradykininIBA 09/2000 - 01/2000
2	RNA (Ribonucleic Acid)IBA 12/2021 - 10/2001
2	pembrolizumabIBA 03/2019 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2001
2	Aluminum Oxide (Sapphire)IBA 02/2014 - 06/2005
2	Infliximab (Remicade)FDA Link 11/2010 - 11/2008
2	CollagenIBA 09/2004 - 10/2000
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2001 - 03/2000
2	Peptides (Polypeptides)IBA 12/2001 - 11/2001
2	Messenger RNA (mRNA)IBA 11/2001 - 03/2000
2	kallistatinIBA 01/2001 - 03/2000
2	SaltsIBA 12/2000 - 09/2000
1	margetuximabIBA 10/2022
1	human ERBB2 proteinIBA 10/2022
1	Trastuzumab (Herceptin)FDA Link 10/2022
1	N-methyladenosineIBA 12/2021
1	6-methyladenineIBA 12/2021
1	Circular RNAIBA 12/2021
1	lixisenatideIBA 01/2020
1	Insulin Glargine (Lantus)FDA Link 01/2020
1	Combined VaccinesIBA 03/2019
1	VaccinesIBA 03/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	dupilumabIBA 01/2019
1	NivolumabIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Antiviral Agents (Antivirals)IBA 10/2016
1	GlucocorticoidsIBA 01/2016
1	zirconium oxide (zirconia)IBA 02/2014
1	titanium alloy (TiAl6V4)IBA 02/2014
1	Bovine Serum AlbuminIBA 10/2009
1	Therapeutic UsesIBA 09/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2001
1	Angiotensin IIIBA 12/2001
1	ReninIBA 12/2001
1	Nitric Oxide Synthase (NO Synthase)IBA 12/2001
1	Superoxides (Superoxide)IBA 11/2001
1	FE 999024IBA 11/2001
1	Keratin-18 (Keratin 18)IBA 11/2001
1	Serine Proteases (Serine Protease)IBA 11/2001
1	matrigelIBA 11/2001
1	Tumor Biomarkers (Tumor Markers)IBA 10/2001

Therapy/Procedure

8	Therapeutics 10/2022 - 05/2001
2	Drug Therapy (Chemotherapy) 10/2022 - 09/2018
1	Immunotherapy 01/2021
1	Neoadjuvant Therapy 09/2018